Shizhao Yang

State Key Laboratory Of Ophthalmology, Guangdong Provincial Key Laboratory Of Ophthalmology And Visual Science
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Corrigendum to "Intravitreal Dexamethasone Implants facilitate the management of Refractory Behçet's Uveitis with vasculitis" [Clinical Immunology 251 (2023) 109633].

Corrigendum to "Intravitreal Dexamethasone Implants facilitate the management of Refractory Behçet's Uveitis with vasculitis" [Clinical Immunology 251 (2023) 109633].

Journal: Clinical immunology (Orlando, Fla.)

Published: January 16, 2024

Intravitreal dexamethasone implants facilitate the management of refractory Behçet's uveitis with vasculitis.

Intravitreal dexamethasone implants facilitate the management of refractory Behçet's uveitis with vasculitis.

Journal: Clinical immunology (Orlando, Fla.)

Published: February 01, 2023

Adalimumab plus Conventional Therapy versus Conventional Therapy in Refractory Non-Infectious Scleritis.

Adalimumab plus Conventional Therapy versus Conventional Therapy in Refractory Non-Infectious Scleritis.

Journal: Journal of clinical medicine

Published: September 27, 2022

Peripheral immune landscape and natural killer-like B cells in human Vogt-Koyanagi-Harada disease.

Peripheral immune landscape and natural killer-like B cells in human Vogt-Koyanagi-Harada disease.

Journal: Life medicine

Published: September 22, 2022

Insights gained from single-cell analysis of immune cells in tofacitinib treatment of Vogt-Koyanagi-Harada disease.

Insights gained from single-cell analysis of immune cells in tofacitinib treatment of Vogt-Koyanagi-Harada disease.

Journal: JCI insight

Published: June 02, 2022

Systemic glucocorticoid-free therapy with adalimumab plus immunosuppressants versus conventional therapy in treatment-naïve Vogt-Koyanagi-Harada disease patients.

Systemic glucocorticoid-free therapy with adalimumab plus immunosuppressants versus conventional therapy in treatment-naïve Vogt-Koyanagi-Harada disease patients.

Journal: Annals of translational medicine

Published: April 11, 2022

Insights gained from Single-Cell analysis of immune cells on Cyclosporine A treatment in autoimmune uveitis.

Insights gained from Single-Cell analysis of immune cells on Cyclosporine A treatment in autoimmune uveitis.

Journal: Biochemical pharmacology

Published: March 07, 2022

Diagnostic value of genetic mutation analysis and mutation profiling of cell-free DNA in intraocular fluid for vitreoretinal lymphoma.

Diagnostic value of genetic mutation analysis and mutation profiling of cell-free DNA in intraocular fluid for vitreoretinal lymphoma.

Journal: Cancer communications (London, England)

Published: February 11, 2022

Adalimumab in Vogt-Koyanagi-Harada Disease Refractory to Conventional Therapy.

Adalimumab in Vogt-Koyanagi-Harada Disease Refractory to Conventional Therapy.

Journal: Frontiers in medicine

Published: October 21, 2021

First observation of intraocular extranodal natural killer/T-cell lymphoma secondary to a retroperitoneal tumour: a case report and comparative review.

First observation of intraocular extranodal natural killer/T-cell lymphoma secondary to a retroperitoneal tumour: a case report and comparative review.

Journal: BMC ophthalmology

Published: July 04, 2021

Unraveling the Heterogeneity and Ontogeny of Dendritic Cells Using Single-Cell RNA Sequencing.

Unraveling the Heterogeneity and Ontogeny of Dendritic Cells Using Single-Cell RNA Sequencing.

Journal: Frontiers in immunology

Published: May 18, 2021

The Efficacy of Adalimumab as an Initial Treatment in Patients with Behçet's Retinal Vasculitis.

The Efficacy of Adalimumab as an Initial Treatment in Patients with Behçet's Retinal Vasculitis.

Journal: Frontiers in pharmacology

Published: January 15, 2021

Showing 1-12 of 14

Last Updated: 09/26/2026